{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:50:53Z","timestamp":1782377453154,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clinthera.2026.03.010","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:10:30Z","timestamp":1775178630000},"page":"432-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reporting and Extent of Glucocorticoid Use in Systemic Sclerosis Randomized Trials: A Meta-Research Study"],"prefix":"10.1016","volume":"48","author":[{"given":"Iulia-Simona","family":"Chiric\u0103","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Iudici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 76","key":"10.1016\/j.clinthera.2026.03.010_bib0001","first-page":"157","article-title":"Glucocorticoids in systemic sclerosis: weighing the benefits and risks\u2014a systematic review","volume":"31","author":"Iudici","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0002","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","article-title":"Scleroderma renal crisis","volume":"29","author":"Steen","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0003","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10067-013-2422-0","article-title":"Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries","volume":"33","author":"Iudici","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0004","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/rheumatology\/keac533","article-title":"Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database","volume":"62","author":"Iudici","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/03009742.2014.957239","article-title":"Glucocorticoids in systemic sclerosis: patients' beliefs and treatment adherence","volume":"44","author":"Iudici","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0006","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1093\/rheumatology\/kead012","article-title":"A phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)","volume":"62","author":"Griffiths-Jones","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0007","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard-2024-226430","article-title":"EULAR recommendations for the treatment of systemic sclerosis: 2023 update","volume":"84","author":"Del Galdo","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0008","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2634","article-title":"High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy","volume":"11","author":"Hunzelmann","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0009","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.40560","article-title":"Treatment algorithms for systemic sclerosis according to experts","volume":"70","author":"Fern\u00e1ndez-Codina","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0010","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0011","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"J Med Libr Assoc"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0012","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jclinepi.2010.02.005","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"63","author":"Schulz","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0013","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.mayocpiqo.2023.04.010","article-title":"Inadequate reporting of cointerventions, other methodological factors, and treatment estimates in cardiovascular trials: a meta-epidemiological study","volume":"7","author":"B\u00fchrer","year":"2023","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0014","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/1740774511410995","article-title":"Clinician-trialist rounds: 5. Cointervention bias\u2014how to diagnose it in their trial and prevent it in yours","volume":"8","author":"Sackett","year":"2011","journal-title":"Clin Trials"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0015","doi-asserted-by":"crossref","first-page":"n2869","DOI":"10.1136\/bmj.n2869","article-title":"Getting the \u201cbalance\u201d right in clinical trials","volume":"375","author":"Abdel Shaheed","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0016","doi-asserted-by":"crossref","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014890","article-title":"Low reporting of cointerventions in recent cardiovascular clinical trials: a systematic review","volume":"9","author":"Moutzouri","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.clinthera.2026.03.010_bib0018","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.semarthrit.2019.03.009","article-title":"Inadequate reporting of concomitant medications in rheumatology randomized controlled trials of pharmacologic interventions","volume":"49","author":"Iudici","year":"2019","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182600072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182600072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:33:29Z","timestamp":1782376409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929182600072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S014929182600072X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.03.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reporting and Extent of Glucocorticoid Use in Systemic Sclerosis Randomized Trials: A Meta-Research Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}